Trials / Terminated
TerminatedNCT03894020
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
A Study of Disease Progression in Genetically Defined Subjects With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 83 (actual)
- Sponsor
- Gyroscope Therapeutics Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study to evaluate the natural progression of dry AMD in genetically defined subjects
Detailed description
Prospective, observational study to evaluate the natural progression of anatomical and functional visual parameters in genetically defined subjects with GA due to AMD.
Conditions
- Dry Age-related Macular Degeneration
- Macular Degeneration
- Retinal Disease
- Retinal Degeneration
- Geographic Atrophy
- Macular Atrophy
Timeline
- Start date
- 2019-01-08
- Primary completion
- 2024-03-25
- Completion
- 2024-03-25
- First posted
- 2019-03-28
- Last updated
- 2024-10-30
Locations
71 sites across 8 countries: United States, Australia, France, Germany, Netherlands, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT03894020. Inclusion in this directory is not an endorsement.